MedAI Verdict
All comparisons

Clarius vs DeepHealth

Bladder and prostate volumes at the bedside are one job, and screening mammograms read in a radiology department are another, so these vendors sell to different buyers. Clarius's Bladder AI (K232257, decided November 13, 2023) and Prostate AI (K243853, decided April 16, 2025) run on its wireless probe, which the company has sold since December 2016 and takes orders for by store checkout or quote request. A urology or primary care clinic is the Clarius buyer.

DeepHealth sells Saige-Dx mammography detection (K253825, decided June 15, 2026) to breast imaging groups and hospital radiology departments, and its homepage shows no price. RadNet announced the DeepHealth acquisition on March 11, 2020. openFDA lists 12 records under Clarius Mobile Health Corp., six of them AI-named, and 10 under DeepHealth, Inc.

Radiology · Reviewed November 2, 2026

Clarius logo

Clarius

by Clarius Mobile Health

Wireless handheld ultrasound scanners with FDA-cleared onboard AI tools for bladder, prostate, OB and cardiac measurement.

DeepHealth logo

DeepHealth

by RadNet / DeepHealth, Inc.

Imaging AI from RadNet's DeepHealth: mammography (Saige-Dx, Saige-Density), breast arterial calcification, prostate, lung, bone and chest X-ray.

When to pick each one

Clarius

  • Bladder and prostate volume measurement on a bedside probe
  • Vendor says wireless probe sold since December 2016
Read the full Clarius review

DeepHealth

  • Saige-Dx mammography detection, latest clearance June 2026
  • Diagnostic Suite and Operations Suite for enterprise imaging
Read the full DeepHealth review

Score

Each row shows points earned of points available under the published rubric.

Clarius

53of 100

Solid choice

DeepHealth

48of 100

Solid choice
Score by dimension for Clarius and DeepHealth
DimensionClariusDeepHealthDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers12.7 / 18.27.3 / 18.2+5.5
RCT / meta-analysis / systematic review7.8 / 7.80 / 7.8+7.8
Funding & adoption signal3 / 1212 / 12-9
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Clarius

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price verified.

DeepHealth

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. The homepage shows none.

Evidence

DeepHealth

FDA decisions

Show 13 more

Peer-reviewed

1 PubMed record names DeepHealth.

Compliance and integrations

Documented from each vendor’s own pages.

SpecClariusDeepHealth
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/an/a
HQn/aUS

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.